Business Context and Reporting Period
Company: Alphatec Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2014 (Signed October 2, 2014)
Context: The filing reports the execution of a definitive Settlement and Release Agreement to resolve the OrthoTec, LLC v. Surgiview, S.A.S, et al. litigation matter and related claims.
Key Financial Metrics and Obligations
This filing details a specific financial obligation rather than general operating results. The filing text does not provide revenue, profit, cash flow, or margin data for the period.
- Total Settlement Amount: $49 million in cash.
- Payments Made to Date: $17.5 million ($1.75 million in March 2014; $15.75 million in June 2014).
- Remaining Principal: $31.5 million.
- Payment Schedule: 28 quarterly installments of $1.1 million, followed by one final installment of $700,000, commencing October 1, 2014.
- Interest Rate: 7% per annum on the unpaid balance, accruing from May 15, 2014.
- Interest Payment Terms: Accrued interest is payable in quarterly installments of $1.1 million (or the full accrued amount if less) after the principal is fully paid.
- Prepayment: The Company has the right to prepay amounts due without penalty.
Material Changes and Agreements
The Company entered into a formal Settlement Agreement on September 26, 2014, which supersedes a previously reported Binding Term Sheet from March 15, 2014. The new agreement contains substantially the same business terms as the term sheet. The agreement provides for mutual releases of all claims in the Superior Court of California, Los Angeles County, and all other related litigation matters involving the Company, its directors, and affiliates.
Management Commentary, Risks, and Related Parties
Related Party Involvement: The settlement involves HealthpointCapital entities and individuals who are principal stockholders and directors of the Company. Specifically, John H. Foster (Chairman and CEO) and Mortimer Berkowitz III (Director) serve in management roles for HealthpointCapital, LLC and its related funds.
Risks and Contingencies: The primary risk addressed is the resolution of ongoing litigation. The filing notes that the summary of the agreement is qualified by reference to the full text of the Binding Term Sheet (filed with the March 31, 2014 10-Q) and the Settlement Agreement (to be filed with the September 30, 2014 10-Q).
Investor Verification Checklist
- Verify the impact of the $31.5 million remaining principal and accrued interest on the Company's liquidity and cash flow projections.
- Confirm the exact interest accrual calculation starting from May 15, 2014, and the timing of the first interest payment.
- Review the full text of the Settlement Agreement (exhibit to the upcoming 10-Q) for any covenants or conditions not summarized in this 8-K.
- Assess the potential for future litigation claims given the scope of the "mutual releases" described.